BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 15001987)

  • 1. Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis.
    Héroult M; Bernard-Pierrot I; Delbé J; Hamma-Kourbali Y; Katsoris P; Barritault D; Papadimitriou E; Plouet J; Courty J
    Oncogene; 2004 Mar; 23(9):1745-53. PubMed ID: 15001987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of heparin affin regulatory peptide on the expression of vascular endothelial growth factor receptors in endothelial cells.
    Kokolakis G; Mikelis C; Papadimitriou E; Courty J; Karetsou E; Katsoris P
    In Vivo; 2006; 20(5):629-35. PubMed ID: 17091770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin affin regulatory peptide/pleiotrophin negatively affects diverse biological activities in C6 glioma cells.
    Parthymou A; Lampropoulou E; Mikelis C; Drosou G; Papadimitriou E
    Eur J Cell Biol; 2008 Jan; 87(1):17-29. PubMed ID: 17881084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of heparin affin regulatory peptide domains with potential role on angiogenesis.
    Polykratis A; Delbé J; Courty J; Papadimitriou E; Katsoris P
    Int J Biochem Cell Biol; 2004 Oct; 36(10):1954-66. PubMed ID: 15203110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenic response of endothelial cells to heparin-binding domain of fibronectin.
    Viji RI; Kumar VB; Kiran MS; Sudhakaran PR
    Int J Biochem Cell Biol; 2008; 40(2):215-26. PubMed ID: 17766169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
    Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
    Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bovine lactoferricin inhibits basic fibroblast growth factor- and vascular endothelial growth factor165-induced angiogenesis by competing for heparin-like binding sites on endothelial cells.
    Mader JS; Smyth D; Marshall J; Hoskin DW
    Am J Pathol; 2006 Nov; 169(5):1753-66. PubMed ID: 17071598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor binding protein-7 (IGFBP7) blocks vascular endothelial cell growth factor (VEGF)-induced angiogenesis in human vascular endothelial cells.
    Tamura K; Hashimoto K; Suzuki K; Yoshie M; Kutsukake M; Sakurai T
    Eur J Pharmacol; 2009 May; 610(1-3):61-7. PubMed ID: 19374835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
    Bae DG; Kim TD; Li G; Yoon WH; Chae CB
    Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HARP induces angiogenesis in vivo and in vitro: implication of N or C terminal peptides.
    Papadimitriou E; Polykratis A; Courty J; Koolwijk P; Heroult M; Katsoris P
    Biochem Biophys Res Commun; 2001 Mar; 282(1):306-13. PubMed ID: 11264008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of heparin on bovine epithelial lens cell proliferation induced by heparin affin regulatory peptide.
    Delbé J; Vacherot F; Laaroubi K; Barritault D; Courty J
    J Cell Physiol; 1995 Jul; 164(1):47-54. PubMed ID: 7790396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The angiogenic factor heparin affin regulatory peptide (HARP) induces proliferation of human peripheral blood mononuclear cells.
    Achour A; Laaroubi D; Caruelle D; Barritault D; Courty J
    Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL73-7. PubMed ID: 11936877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF and inhibitors of TGFbeta type-I receptor kinase synergistically promote blood-vessel formation by inducing alpha5-integrin expression.
    Liu Z; Kobayashi K; van Dinther M; van Heiningen SH; Valdimarsdottir G; van Laar T; Scharpfenecker M; Löwik CW; Goumans MJ; Ten Dijke P; Pardali E
    J Cell Sci; 2009 Sep; 122(Pt 18):3294-302. PubMed ID: 19706683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.
    Sun J; Blaskovich MA; Jain RK; Delarue F; Paris D; Brem S; Wotoczek-Obadia M; Lin Q; Coppola D; Choi K; Mullan M; Hamilton AD; Sebti SM
    Cancer Res; 2004 May; 64(10):3586-92. PubMed ID: 15150116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor receptor-2 and low affinity VEGF binding sites on human glomerular endothelial cells: Biological effects and advanced glycosilation end products modulation.
    Pala L; Cresci B; Manuelli C; Maggi E; Yamaguchi YF; Cappugi P; Rotella CM; Giannini S
    Microvasc Res; 2005 Nov; 70(3):179-88. PubMed ID: 16271941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial cell proliferation induced by HARP: implication of N or C terminal peptides.
    Papadimitriou E; Heroult M; Courty J; Polykratis A; Stergiou C; Katsoris P
    Biochem Biophys Res Commun; 2000 Jul; 274(1):242-8. PubMed ID: 10903925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An engineered heparin-binding form of VEGF-E (hbVEGF-E). Biological effects in vitro and mobilizatiion of precursor cells.
    Heil M; Mitnacht-Krauss R; Issbrücker K; van den Heuvel J; Dehio C; Schaper W; Clauss M; Weich HA
    Angiogenesis; 2003; 6(3):201-11. PubMed ID: 15041796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudolarix acid B inhibits angiogenesis by antagonizing the vascular endothelial growth factor-mediated anti-apoptotic effect.
    Tan WF; Zhang XW; Li MH; Yue JM; Chen Y; Lin LP; Ding J
    Eur J Pharmacol; 2004 Sep; 499(3):219-28. PubMed ID: 15381043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-angiogenic action of plasma hyaluronan binding protein in human umbilical vein endothelial cells.
    Jeon JW; Song HS; Moon EJ; Park SY; Son MJ; Jung SY; Kim JT; Nam DH; Choi-Miura NH; Kim KW; Kim YJ
    Int J Oncol; 2006 Jul; 29(1):209-15. PubMed ID: 16773202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum response factor is a critical requirement for VEGF signaling in endothelial cells and VEGF-induced angiogenesis.
    Chai J; Jones MK; Tarnawski AS
    FASEB J; 2004 Aug; 18(11):1264-6. PubMed ID: 15180964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.